1. IIMB-
  2. Faculty Publications
  3. Projects
  4. 2011-2012
Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/21403
DC FieldValueLanguage
dc.contributor.authorChatterjee, Chirantan
dc.contributor.authorKubo, Kensuke
dc.contributor.authorPingali, Viswanath
dc.date.accessioned2022-07-24T14:45:51Z-
dc.date.available2022-07-24T14:45:51Z-
dc.date.issued2012-01-06
dc.identifier.urihttps://repository.iimb.ac.in/handle/2074/21403-
dc.description.abstractThe Indian pharmaceutical industry is characterized by intense inter-firm competition and a high degree of heterogeneity in product quality. The former aspect is due to the lack of patent protection for pharmaceutical innovations – except for those relating to manufacturing processes – until 2005, and the existence of a thriving local generic drug industry. These are the same factors that have in recent times contributed to India’s rise as one of the world’s largest producers and exporters of generic pharmaceuticals (Chaudhuri, 2005).
dc.publisherIndian Institute of Management Bangalore
dc.relationSupplier behavior and product quality in Indian pharmaceutical markets: Implications for price regulation and patent enforcement from pharmaceutical demand in India
dc.relation.ispartofseriesIIMB_PR_2011-12_013
dc.subjectPharmaceutical industry
dc.subjectIndian pharmaceutical industry
dc.subjectPharmaceutical markets
dc.subjectSupplier behavior
dc.subjectPharmaceutical innovations
dc.titleSupplier behavior and product quality in Indian pharmaceutical markets: Implications for price regulation and patent enforcement from pharmaceutical demand in India
dc.typeProject-IIMB
Appears in Collections:2011-2012
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.